These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 29492965

  • 61. Role of HER2 in Prognosis of Salivary Duct Carcinoma: A Systematic Review and Meta-Analysis.
    Williams CYK, Townson AT, Terry N, Schmitt NC, Sharma A.
    Laryngoscope; 2023 Mar; 133(3):476-484. PubMed ID: 35567387
    [Abstract] [Full Text] [Related]

  • 62. Stage as major long term outcome predictor in minor salivary gland carcinoma.
    Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Keus RB, Hart AA.
    Cancer; 2000 Sep 15; 89(6):1195-204. PubMed ID: 11002213
    [Abstract] [Full Text] [Related]

  • 63. [Clinical analysis of 61 cases of salivary duct carcinoma].
    Chen F, Wang LW, Bu JQ.
    Zhonghua Yi Xue Za Zhi; 2022 May 17; 102(18):1394-1397. PubMed ID: 35545586
    [Abstract] [Full Text] [Related]

  • 64. Spreading patterns, prognostic factors and treatment outcomes of nasopharyngeal papillary adenocarcinoma and salivary gland-type carcinomas.
    Liu LZ, Zhang YM, Chen Y, Li L.
    Clin Otolaryngol; 2016 Apr 17; 41(2):160-8. PubMed ID: 26118586
    [Abstract] [Full Text] [Related]

  • 65. Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.
    Udager AM, Chiosea SI.
    Head Neck Pathol; 2017 Sep 17; 11(3):288-294. PubMed ID: 28321773
    [Abstract] [Full Text] [Related]

  • 66. Salivary duct carcinoma in the mandible: a case report.
    Kikuchi Y, Hirota M, Iwai T, Aoki S, Chikumaru H, Kawabe R, Matsui Y.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar 17; 103(3):e41-6. PubMed ID: 17321438
    [Abstract] [Full Text] [Related]

  • 67. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.
    Williams L, Thompson LD, Seethala RR, Weinreb I, Assaad AM, Tuluc M, Ud Din N, Purgina B, Lai C, Griffith CC, Chiosea SI.
    Am J Surg Pathol; 2015 May 17; 39(5):705-13. PubMed ID: 25871467
    [Abstract] [Full Text] [Related]

  • 68. Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases.
    Simpson RH, Prasad AR, Lewis JE, Skálová A, David L.
    Am J Surg Pathol; 2003 Aug 17; 27(8):1070-9. PubMed ID: 12883239
    [Abstract] [Full Text] [Related]

  • 69. Salivary duct carcinoma: what is already known, and can we improve survival?
    Wee DT, Thomas AA, Bradley PJ.
    J Laryngol Otol; 2012 Jul 17; 126 Suppl 2():S2-7. PubMed ID: 22495125
    [Abstract] [Full Text] [Related]

  • 70. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
    Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T.
    Histopathology; 2017 Jan 17; 70(2):164-173. PubMed ID: 27079821
    [Abstract] [Full Text] [Related]

  • 71. Prognostic markers in salivary gland cancer and their impact on survival.
    Szewczyk M, Marszałek A, Sygut J, Golusiński P, Golusiński W.
    Head Neck; 2019 Sep 17; 41(9):3338-3347. PubMed ID: 31246357
    [Abstract] [Full Text] [Related]

  • 72. Salivary duct carcinoma: Treatment, outcomes, and patterns of failure.
    Johnston ML, Huang SH, Waldron JN, Atenafu EG, Chan K, Cummings BJ, Gilbert RW, Goldstein D, Gullane PJ, Irish JC, Perez-Ordonez B, Weinreb I, Bayley A, Cho J, Dawson LA, Hope A, Ringash J, Witterick IJ, O'Sullivan B, Kim J.
    Head Neck; 2016 Apr 17; 38 Suppl 1():E820-6. PubMed ID: 25916947
    [Abstract] [Full Text] [Related]

  • 73. [Salivary duct carcinoma of the sublingual gland--a case report].
    Sartorius C, Gille F, Bédrossian-Pfingsten J, Kempf HG.
    Laryngorhinootologie; 2006 Jul 17; 85(7):517-9. PubMed ID: 16586279
    [Abstract] [Full Text] [Related]

  • 74. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.
    Griffith CC, Thompson LD, Assaad A, Purgina BM, Lai C, Bauman JE, Weinreb I, Seethala RR, Chiosea SI.
    Histopathology; 2014 Dec 17; 65(6):854-60. PubMed ID: 24804831
    [Abstract] [Full Text] [Related]

  • 75. Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required?
    Lee JS, Kwon OJ, Park JJ, Seo JH.
    J Oral Maxillofac Surg; 2014 May 17; 72(5):1023-31. PubMed ID: 24480767
    [Abstract] [Full Text] [Related]

  • 76. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China.
    Zhu F, Liu Z, Hou Y, He D, Ge X, Bai C, Jiang L, Li S.
    J Thorac Oncol; 2013 Dec 17; 8(12):1578-84. PubMed ID: 24389442
    [Abstract] [Full Text] [Related]

  • 77. Primary salivary gland-type carcinomas of the nasopharynx: prognostic factors and outcome.
    Cao CN, Zhang XM, Luo JW, Xu GZ, Gao L, Li SY, Xiao JP, Yi JL, Huang XD, Liu SY, Xu ZG, Tang PZ.
    Int J Oral Maxillofac Surg; 2012 Aug 17; 41(8):958-64. PubMed ID: 22579955
    [Abstract] [Full Text] [Related]

  • 78. Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification Model.
    Nakaguro M, Sato Y, Tada Y, Kawakita D, Hirai H, Urano M, Shimura T, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Fushimi C, Shimizu A, Takase S, Okada T, Sato H, Imanishi Y, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Saigusa N, Takahashi H, Ando M, Hanazawa T, Nagao T.
    Am J Surg Pathol; 2020 Apr 17; 44(4):526-535. PubMed ID: 31764219
    [Abstract] [Full Text] [Related]

  • 79. Prognostic models for estimating survival of salivary duct carcinoma: a population-based study.
    Zhang D, Li L.
    Eur Arch Otorhinolaryngol; 2023 Apr 17; 280(4):1939-1954. PubMed ID: 36422671
    [Abstract] [Full Text] [Related]

  • 80. Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy.
    Scherl C, Haderlein M, Agaimy A, Mantsopoulos K, Koch M, Traxdorf M, Fietkau R, Grundtner P, Iro H.
    Strahlenther Onkol; 2019 Dec 17; 195(12):1050-1059. PubMed ID: 31350567
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.